Abbvie Inc ABBV:NYSE

Last Price$152.49NYSE Previous Close - Last Trade as of 7:00PM ET 6/28/22

Today's Change-0.65(0.42%)
Bid (Size)$148.92 (1)
Ask (Size)$154.20 (2)
Day Low / High$151.39 - 155.12

AbbVie Says It Has Filed New Drug Application With FDA for Advanced Parkinson's Disease Treatment

9:10AM ET 5/20/2022 MT Newswires
AbbVie (ABBV) said Friday it has filed a new drug application with the US Food and Drug Administration for its ABBV-951 treatment of motor fluctuations in patients with advanced Parkinson's disease.

ABBV-951 is designed to provide 24-hour continuous subcutaneous delivery of the combination carbidopa/levodopa medication, the company said.

The FDA submission is based on results from a phase 3 clinical trial in which ABBV-951 showed "statistically significant improvement" in controlling involuntary movements in advanced Parkinson's disease patients compared with oral immediate-release carbidopa/levodopa, AbbVie said.

The company will continue to seek regulatory submissions for ABBV-951 across international markets this year, it said.

Price: 152.96, Change: +1.24, Percent Change: +0.82